-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Benzinga·12/04/2025 18:05:29
语音播报
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.